Search Within

Department of Medicine

Formats
  1. Journal Article (19572)
  2. Meeting Abstract (16038)
  3. Review (1147)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (235)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22311)
  2. Hematologic Malignancies, Division of (13264)
  3. Center for Hematologic Malignancies (11049)
  4. GSK Faculty (10640)
  5. Survivorship Research (9323)
  6. Division of Subspecialty Medicine (7531)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1068)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1043)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3721)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6456)
  2. Elsevier Inc. (4213)
  3. American Society of Hematology (4000)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2109)

More Publishers

Results (39594)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/Ib study of inavolisib (INAVO) alone and in combination with endocrine therapy ± palbociclib (PALBO) in patients (pts) with PIK3CA-mutated, hormone receptor–positive, HER2-negative locally advanced/metastatic breast cancer (HR+, HER2– LA/mBC): Analysis of hyperglycemia (HG) in prediabetic/obese pts.
    Meeting Abstract

    Oliveira, M.; Accordino, M. K.; Cervantes, A.; Gambardella, V.; Hamilton, E. P.; Italiano, A.; Jhaveri, K. L.; Juric, D.; Kalinsky, K.; Krop, I. E.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment-related neutropenia as a predictor of response to adjuvant palbociclib in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
    Meeting Abstract

    Fanucci, K.; Dueck, A. C.; Mayer, E. L.; Martin, M.; Haddad, T. C.; Zdenkowski, N.; Steger, G. G.; Novik, Y.; Suga, J. M.; Lemieux, J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Real-world (RW) analysis of characteristics and risk of recurrence (ROR) in Black patients (pts) with HR+/HER2-early breast cancer (EBC) eligible for NATALEE
    Meeting Abstract

    Abdou, Y.; Reid, S. A.; Jhaveri, K. L.; Pegram, M. D.; Schlam, I.; Sparano, J. A.; Olumba, B. T.; Santarsiero, E. C.; Ganapathy, V.; Akdere, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Impact of initial chemotherapy dosing on subsequent dosing patterns and treatment completion in early-stage breast cancer
    Meeting Abstract

    Iglesias, M. J. M.; O'Connell, K.; Bhimani, J.; Blinder, V. S.; Doud, R. P.; Gallagher, G. B.; Griggs, J. J.; Kolevska, T.; Kroenke, C.; Laurent, C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Obesity, chemotherapy dosing, and toxicity: Results from the Optimal Breast Cancer Chemotherapy Dosing study
    Meeting Abstract

    Kantor, E.; O'Connell, K.; Bhimani, J.; Blinder, V. S.; Doud, R. P.; Gallagher, G. B.; Griggs, J. J.; Monroy-Iglesias, M. J.; Kolevska, T.; Kroenke, C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Imlunestrant with or without abemaciclib in advanced breast cancer (ABC): Safety analyses from the phase III EMBER-3 trial
    Meeting Abstract

    O'Shaughnessy, J.; Bidard, F. C.; Neven, P.; Casalnuovo, M. L.; Aftimos, P. G.; Manich, C. S.; Harbeck, N.; Carey, L. A.; Curigliano, G.; García-Sáenz, J. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Pilot study of an enhanced telehealth program for patients with prostate cancer
    Meeting Abstract

    Bange, E. M.; Reiner, A. S.; Liebertz, C.; Chimonas, S.; Daly, R. M.; Malling, C.; Lei, S.; Campbell, R.; Stevanovic, K.; Holland, J. C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Circulating tumor DNA (ctDNA) dynamics as a predictor of treatment response in metastatic breast cancer (mBC)
    Meeting Abstract

    Razavi, P.; Cabel, L.; Teysir, J.; An, J. A. R.; Rivero-Hinojosa, S.; Satta, S.; Bristow, S. L.; Kalashnikova, E.; Rodriguez, A. A.; Liu, M. C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Randomized study evaluating optimal dose, efficacy and safety of E7386 + lenvatinib versus treatment of physicians’ choice in advanced/recurrent endometrial carcinoma previously treated with anti-PD-(L)1 immunotherapy
    Meeting Abstract

    Eskander, R. N.; Lee, J. Y.; Mirza, M.; Lorusso, D.; Mackay, H.; Ray-Coquard, I.; Oaknin, A.; Gonzalez-Martin, A.; Hase-gawa, K.; Corr, B.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Longer-term safety and efficacy of selinexor maintenance therapy for patients with TP53wt advanced or recurrent endometrial cancer: Follow-up subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO Study
    Meeting Abstract

    Valabrega, G.; Vergote, I.; Richardson, D.; Pérez-Fidalgo, A.; Van Gorp, T.; Sehouli, J.; Weinberger, V.; Bruchim, I.; Oza, A.; Spitz, D. L.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save